Identification and characterisation of carnostatine (SAN9812), a potent and selective carnosinase (CN1) inhibitor with in vivo activity
Jiedong Qiu(Heidelberg University), Aimo Kannt(Goethe University Frankfurt), Thomas Albrecht(Roche (Switzerland)), Diego O. Pastene(Heidelberg University), Verena Peters(Heidelberg University), Benito Yard(Heidelberg University), Angelica Rodriguez-Niño(Heidelberg University), Markus Kohlmann(Sanofi (Germany)), Sven Ruf(Sanofi (France)), Michael Teufel(Bayer (United States)), Hans‐Peter Hammes(Heidelberg University), Sibylle J. Hauske(Heidelberg University), Shiqi Zhang(Chengdu Institute of Biology), Harry van Goor(University Medical Center Groningen), Jacob van den Born(University Medical Center Groningen), Bernhard K. Krämer
Cited by 42
Related Papers
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
|The Lancet|2022|1k
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function
|Nature Communications|2016|545
Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction
|Nature Medicine|2017|493
Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation
|Proceedings of the National Academy of Sciences|2009|342
Criteria for definition of a complex abdominal wall hernia
|Hernia|2013|340